
    
      Based on patients, who are treated in the University Cancer Center Hamburg (UCCH) and its
      contracted partner network, which comprises all cancer treating departments at the University
      Medical Center of Hamburg-Eppendorf (UKE), as well as 19 office-based oncologists and 20
      surrounding hospitals, recruitment for the study will be done as follows:

      (i) as a cancer patient during regular aftercare appointments who reports a current or past
      COVID-19 infection.

      (ii) as an acute COVID-19 patient who reports a prevalent cancer diagnosis

      Data will be collected as available from routine clinical care and includes demographic and
      biometric data, medical history, baseline data at inclusion as well as inpatient and
      intensive care unit admissions. Upon consent, patients will provide peripheral blood samples
      at time of inclusion and after 6 month. Recruitment is limited to a one-year period (April
      2020 - April 2021).
    
  